Industrial gas producer and supplier,
) hosted its Investor Day 2013 on Sep 16, 2013. Discussions on
the financial aspects of the company's goals are briefed below.
BRASKEM SA (BAK): Free Stock Analysis Report
EASTMAN CHEM CO (EMN): Free Stock Analysis
LSB INDS INC (LXU): Free Stock Analysis
PRAXAIR INC (PX): Free Stock Analysis Report
To read this article on Zacks.com click here.
Praxair's management believes that the company is among the
leading industrial gas producers worldwide. Long-term growth
prospects are quite bright for the company due to growing
preferences among customers for Praxair's world class technology,
high quality products and gas supply services.
The company's intense focus on continuous expansion of its
operating regions and addition of new customers to its existing
sphere of businesses will help accelerate profit growth in the
For a 5-year period (2012-2017), Praxair targets to achieve high
single-digit sales growth, roughly 8% CAGR. This includes 2%-3%
contribution from base volume growth, 1%-2% from price, 3%-4%
growth from projects and roughly 1% from acquisitions.
Sales by 2017 are expected to approximate $16 billion of which
roughly 49% is likely to be sourced from North America, 18% South
America, 11% Europe, 17% Asia and 5% Surface Technologies.
Considering the supply mode, Merchant sales are expected to be
32% of total sales, On-Site sales roughly 29%, Packaged sales 29%
and Others roughly 10%.
Of the end markets, manufacturing is likely to be 25% of sales,
Metals 17%, Energy 14%, Chemicals 11%, Healthcare 6%, Electronics
8%, Food & Beverages 8%, Aerospace 2% and Others 9%.
Praxair anticipates operating profit to grow to exceed sales
growth, earnings per share to register double-digit growth and
return on capital (ROC) to fall within 14%-15% range. The company
anticipates hydrogen sales growth to reach $1.7 billion by 2017.
Cash flow generation from operating activities are anticipated to
reach $17 billion or 24% of sales. Of this, roughly $7 billion is
likely to be returned back to the shareholders through dividend
payments and share buybacks. The remaining $10 billion is likely
to be invested in the Americas, Asia and Europe.
The current Zacks Consensus Estimate for Praxair for years 2013
and 2014 are pegged at $5.95 and $6.70, reflecting annual growth
of 6.8% and 12.7%, respectively. Estimated 3-5 years earnings
growth rate for the company is 11.6% as compared with just 9.6%
for the peer group.
Praxair has a market capitalization of roughly $36.0 billion and
bears a Zacks Rank #3 (Hold). Other stocks to watch out for in
the industry are
Eastman Chemical Co.
LSB Industries Inc.
), each with a Zacks Rank #2 (Buy).